Pacira BioSciences, Inc. (PCRX) earnings
Quarterly results of Pacira BioSciences, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Pacira BioSciences, Inc. was expected to report around October 23, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Pacira BioSciences, Inc. reported revenue of $192.4M (+6.2% on the same quarter a year earlier) and net income of $4.7M.
Diluted earnings per share were $0.12.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $192.4M | +6.2% | $4.7M | $0.12 |
| Q1 FY2026 | $177.4M | +5% | $2.9M | $0.07 |
| Q4 FY2025 | $196.9M | +5.1% | $1.6M | - |
| Q3 FY2025 | $179.5M | +6.5% | $5.4M | $0.12 |
| Q2 FY2025 | $181.1M | - | -$4.8M | -$0.11 |
| Q1 FY2025 | $168.9M | - | $4.8M | $0.10 |
| Q4 FY2024 | $187.3M | - | $16M | - |
| Q3 FY2024 | $168.6M | - | -$143.5M | -$3.11 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
When is Pacira BioSciences, Inc.'s next earnings date?
Pacira BioSciences, Inc. was expected to report around October 23, 2026; nothing is on file with the SEC yet.
What were Pacira BioSciences, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Pacira BioSciences, Inc. reported revenue of $192.4M and net income of $4.7M. The figures come from its filing with the SEC.
Is Pacira BioSciences, Inc.'s revenue growing?
Revenue in Q2 FY2026 was $192.4M, up 6.2% from $181.1M in the same quarter a year earlier.
Get an email when PCRX reports
Follow PCRX and we email you its next results the day they are filed, with the numbers explained.